South Dakota Investment Council’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-7,422
Closed -$649K 612
2021
Q4
$649K Buy
+7,422
New +$616K 0.01% 518
2017
Q2
Sell
-16,472
Closed -$1.1M 596
2017
Q1
$1.1M Hold
16,472
0.02% 399
2016
Q4
$1.07M Buy
16,472
+7,990
+94% +$518K 0.02% 388
2016
Q3
$600K Hold
8,482
0.01% 459
2016
Q2
$627K Hold
8,482
0.01% 441
2016
Q1
$551K Buy
+8,482
New +$577K 0.01% 443

Other funds holding NVS

South Dakota Investment Council's NVS Position: Q1 2022 in Review

South Dakota Investment Council sold out of Novartis (NVS) in Q1 2022, closing a stake of 7,422 shares — an estimated $649K sold.

South Dakota Investment Council first reported a position in NVS in Q1 2016 and held it in 6 quarters. The position peaked at $1.1M in Q1 2017. 1,137 funds tracked by Wall St. Rank hold NVS as of Q1 2022.

  • South Dakota Investment Council reported no remaining Novartis position as of Q1 2022 after selling out during the quarter.
  • South Dakota Investment Council sold 7,422 Novartis shares in Q1 2022, an estimated $649K.
  • South Dakota Investment Council first reported a position in Novartis in Q1 2016 and held it in 6 quarters.
  • South Dakota Investment Council's Novartis position peaked at $1.1M in Q1 2017.
  • 1,137 funds tracked by Wall St. Rank held Novartis as of Q1 2022.

Based on South Dakota Investment Council's 13F filing for Q1 2022, filed 10 May 2022.